Introduction {#S1}
============

Human leukocyte antigen (HLA) genes, which encode major histocompatibility complex proteins in humans, are located in the short arm of chromosome 6 ([@B3]). These encoded HLA proteins are displayed on the cell surface and can be classified into two distinct classes. Class I HLA proteins (A, B, and C) present intracellular antigens originating from viruses or tumors to cytotoxic T lymphocytes. Class II HLA proteins (DR, DQ, and DP) present extracellular antigens to T-helper cells. HLA genes are highly polymorphic and play an important role in immune-mediated diseases, tumor-development processes, transplanted organ or tissue survival determination, and drug hypersensitivity ([@B13]; [@B14]; [@B28]; [@B5]; [@B12]; [@B48]).

HLA genotyping is a complex procedure due to the extreme degree of polymorphism in the major histocompatibility complex family. The most polymorphic regions, known as the core exons, are exons 2 and 3 in HLA class I genes and exon 2 in HLA class II genes. The sequences of the core exons are the most popular targets for genotyping as they are believed to be essential determinants of antigen specificity, which is informative for transplantation. However, in population genetic and evolutionary studies, many polymorphisms in other exons, introns, and UTRs have been identified and contribute to creating HLA nomenclature ([@B37]). Currently, HLA typing is performed using DNA-based methods, including SSP- (sequence-specific primer), SSO- (sequence-specific oligonucleotide), and RFLP-PCR (restriction fragment length polymorphism polymerase chain reaction) and sequence-based typing (SBT) ([@B46]; [@B8]; [@B15]). SBT was considered the gold-standard method for high-resolution HLA genotyping, although this technique may produce uncertain results due to insufficient sequencing and ambiguous haplotype phasing ([@B15]). Recent advancements in next-generation sequencing (NGS) technologies have significantly impacted the HLA-typing process ([@B1]; [@B6]; [@B16]; [@B15]; [@B43]; [@B25], [@B27]; [@B41]). These new approaches can overcome the usual phase ambiguity of HLA alleles and enable massive, parallel, high-resolution HLA-typing. Different NGS-based HLA-typing methods have been established, such as amplicon-based HLA sequencing ([@B7]; [@B43]; [@B25]; [@B41]), target enrichment of HLA genes ([@B54]), and whole exome or genome sequencing data-derived typing ([@B33]; [@B35]).

Only a few studies have been performed to analyze HLA allele and haplotype frequency in the Vietnamese population ([@B51]; [@B10]; [@B24]). Moreover, these studies failed to present detailed HLA information due to low-resolution or incomplete loci description. There is an urgent need for an HLA-typing procedure that can yield accurate and detailed HLA allele distribution. Previous studies have investigated HLA allele distribution among the Kinh population in northern Vietnam, but this study aimed to perform high-resolution HLA typing (3-field) via NGS and determine the frequency of specific alleles and haplotypes of HLA-A, -B, -C, -DRB1, and -DQB1 in southern Kinh Vietnamese populations.

Materials and Methods {#S2}
=====================

Subjects {#S2.SS1}
--------

A descriptive, cross-sectional study was conducted involving 101 unrelated healthy individuals. All subjects, who originated from Ho Chi Minh City and the surrounding Mekong delta provinces, were self-identified as Kinh Vietnamese and were recruited at the University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam from August to October 2017. The study was approved by the Ethics Committee of the University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. All subjects were counseled and provided written informed consent for the study.

DNA Extraction {#S2.SS2}
--------------

Venous blood (2 ml) was collected from each subject using an EDTA anticoagulant tube. Genomic DNA was extracted from peripheral blood leukocytes using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol, and samples were stored at −20°C until analysis.

Genomic DNA quality was assessed by measuring absorbance at 260 nm using a NanoDrop 2000 (Thermo Scientific, MA, United States), and the optical density (OD) ratio (260/280 nm) was calculated to evaluate sample purity. The recommended purified genomic DNA concentration (≥30 μg/μL) and OD ratio (≥1.8) for library preparation were ascertained.

Library Preparation {#S2.SS3}
-------------------

The HLA TruSight kit (CareDx, Brisbane, CA, United States) was used for library preparation. Library construction began with a long-range PCR for full-length HLA-A, -B, -C, -DRB1, -DQB1 loci. All amplicons were normalized to prevent sequencing bias between samples by using magnetic beads consisting of carboxy-coated paramagnetic particles ([@B23]). The beads bound saturating amounts of DNA, and the DNA concentration was normalized to a similar concentration across samples after the washing and elution steps ([@B26]). Subsequently, the DNA amplicons were fragmented into approximately 2-kb pieces, indexed, and pooled for sequencing on the MiniSeq platform (Illumina, San Diego, CA, United States). The pooled library was quantitated before loading on MiniSeq as the library concentration determines cluster density, which is an important parameter for data quality. As instructed in the Illumina protocol, a Qubit 3.0 fluorometer (Thermo Scientific, Waltham, MA, United States) was used for library quantitation. The pooled library was loaded unto the MiniSeq system when its concentration was ≥10 ng/μL.

Sequencing {#S2.SS4}
----------

Next-generation sequencing was performed via the MiniSeq system. Each sample was examined for average depth of coverage and Q30 quality scores, which were \>200 and 85, respectively, for all five loci. The sequences were subsequently analyzed using an Assign TruSight HLA v2.0 (CareDx, Brisbane, CA, United States).

HLA Assigned by Assign TruSight HLA v2.0 {#S2.SS5}
----------------------------------------

Qualified FASTQ files from the MiniSeq system were analyzed by Assign TruSight HLA v2.0 (CareDx, Brisbane, CA, United States). Results with 0 core exon mismatch and phasing ≤2 were accepted. Although full-length HLA loci were sequenced, the maximum resolution that the software Assign TruSight HLA v2.0 can provide is 3-field. Higher resolution (4-field) can be achieved if other analysis tools are applied to assign HLA alleles.

Statistical Analysis {#S2.SS6}
--------------------

For single-locus analysis, allele frequencies were calculated by direct counting, deviation from Hardy--Weinberg (HW) proportions was calculated via chi-square test, and the Ewens--Watterson (EW) homozygosity test of neutrality was also performed via Monte-Carlo implementation of the exact test ([@B17]; [@B52]; [@B44]). The calculation was executed in PyPop: Python for Population Genomics ([@B30]). For multiple-locus analysis, haplotype frequencies were estimated using an expectation-maximization algorithm by Arlequin ver. 3.5 with default settings ([@B18]); linkage disequilibrium (LD) between all HLA allele pairs was analyzed in PyPop, in which D′ and Wn of specific allele pairs were calculated ([@B30]). LD between all HLA loci pairs was further calculated and plotted using conditional asymmetric linkage disequilibrium (ALD) measures ([@B49]). The principal component analysis (PCA) of HLA-A, -B, and -DRB1 was performed using Excel 2010 to compare allele distribution between our data (*n* = 101) and HLA allele frequency data of the Vietnamese Hanoi Kinh population 2 (*n* = 170), Chinese Canton Han population (*n* = 264), Indonesian Sundanese and Javanese population (*n* = 201), Thai population (*n* = 142), Japanese population 3 (*n* = 1018), South Korean population 3 (*n* = 485), and Malaysian Peninsular Malay population (*n* = 951), which were retrieved from the Allele Frequencies Net Database ([allelefrequencies.net](allelefrequencies.net)) ([@B22]). Due to the unavailability of 3-field HLA data in previous studies, we converted 3-field to 2-field data. For example, HLA-A^∗^24:02:01, A^∗^24:02:13, and A^∗^24:02:40 were converted to HLA-A^∗^24:02 with a frequency (0.13861) that was the sum of the three 3-field alleles (0.12871, 0.00495, and 0.00495, respectively). PCA results were plotted using BioVinci software (BioTuring Inc., San Diego, CA, United States).

Results {#S3}
=======

Advancements in NGS offer the ability to distinguish between a set of alleles that share two field names and differ in the third field, such as A^∗^24:02, C^∗^07:01, and DQB1^∗^05:02, in one sequencing batch. As the polymorphisms of A^∗^24:02:40, A^∗^24:02:13, C^∗^07:01:02, and DQB1^∗^05:02:02 are not in the core exons, several traditional PCR and sequencing reactions were required to determine these alleles before NGS methods became available.

Allele Frequencies {#S3.SS1}
------------------

The number of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 alleles detected in this study were 28, 41, 21, 26, and 25, respectively. The frequencies of HLA class I and class II alleles are summarized in [Table 1](#T1){ref-type="table"}. HLA-A^∗^11:01:01, A^∗^24:02:01, and A^∗^33:03:01 (22.77, 12.87, and 10.89%) were the three most frequent HLA-A alleles, followed by A^∗^02:07:01, A^∗^29:01:01, and A^∗^02:03:01 (9.90, 8.42, and 7.43%, respectively). HLA-B^∗^15:02:01, B^∗^46:01:01, B^∗^58:01:01, B^∗^40:01:02, B^∗^38:02:01, and B^∗^07:05:01 (11.88, 9.41, 8.42, 7.92, 7.92, and 6.93%, respectively) were the most frequent HLA-B alleles. The most frequent alleles in locus C were HLA-C^∗^07:02:01, C^∗^01:02:01, and C^∗^08:01:01 (21.78, 13.37, and 12.87%). HLA-DRB1^∗^12:02:01 accounted for 22.28% of the HLA-DRB1 alleles. HLA-DRB1^∗^09:01:02 was the second most frequent allele (13.37%), followed by DRB1^∗^15:02:01, DRB1^∗^10:01:01, DRB1^∗^03:01:01, and DRB1^∗^04:05:01 (9.90, 7.92, 7.42, 6.44%, respectively). On the HLA-DQB1 locus, DQB1^∗^03:01:01 was the most frequent allele (28.71%), followed by DQB1^∗^03:03:02, DQB1^∗^05:01:01, and DQB1^∗^05:02:01 (12.87, 10.89, and 9.90%, respectively).

###### 

HLA frequency in the Kinh population (*n* = 101) (AF: allele frequency).

  **A**      **Count**   **AF**    **C**      **Count**   **AF**    **B**      **Count**   **AF**    **DRB1**   **Count**   **AF**    **DQB1**   **Count**   **AF**
  ---------- ----------- --------- ---------- ----------- --------- ---------- ----------- --------- ---------- ----------- --------- ---------- ----------- ---------
  01:01:01   3           0.01485   01:02:01   27          0.13366   07:02:01   4           0.01980   03:01:01   15          0.07426   02:01:01   14          0.06931
  02:01:01   6           0.02970   03:02:02   18          0.08911   07:05:01   14          0.06931   04:01:01   1           0.00495   02:02:01   4           0.01980
  02:03:01   15          0.07426   03:03:01   9           0.04455   08:01:01   1           0.00495   04:03:01   3           0.01485   03:01:01   58          0.28713
  02:03:02   1           0.00495   03:04:01   15          0.07426   13:01:01   6           0.02970   04:05:01   13          0.06436   03:02:01   5           0.02475
  02:06:01   6           0.02970   03:04:02   1           0.00495   13:02:01   2           0.00990   04:06:01   2           0.00990   03:03:02   26          0.12871
  02:07:01   20          0.09901   03:17      1           0.00495   15:01:01   2           0.00990   07:01:01   6           0.02970   03:03:05   1           0.00495
  03:01:01   1           0.00495   04:01:01   10          0.04950   15:02:01   24          0.11881   08:03:02   11          0.05445   03:05:02   1           0.00495
  03:02:01   2           0.00990   04:03:01   15          0.07426   15:11:01   1           0.00495   08:12      1           0.00495   04:01:01   10          0.04950
  11:01:01   46          0.22772   04:82      1           0.00495   15:12      3           0.01485   09:01:02   27          0.13366   04:02:01   2           0.00990
  11:02:01   5           0.02475   06:02:01   4           0.01980   15:13:01   1           0.00495   10:01:01   16          0.07921   05:01:01   22          0.10891
  11:04      2           0.00990   07:01:01   1           0.00495   15:17:01   1           0.00495   11:01:01   5           0.02475   05:01:03   2           0.00990
  24:02:01   26          0.12871   07:01:02   1           0.00495   15:25:01   11          0.05446   11:06:01   3           0.01485   05:01:12   1           0.00495
  24:02:13   1           0.00495   07:02:01   44          0.21782   15:27:01   1           0.00495   11:129     1           0.00495   05:02:01   20          0.09901
  24:02:40   1           0.00495   07:04:01   2           0.00990   15:35      2           0.00990   12:02:01   45          0.22277   05:02:02   2           0.00990
  24:03:01   2           0.00990   07:06      1           0.00495   18:01:01   2           0.00990   13:01:01   1           0.00495   05:02:04   1           0.00495
  24:07:01   6           0.02970   08:01:01   26          0.12871   18:02      1           0.00495   13:02:01   3           0.01485   05:03:01   5           0.02475
  24:10:01   1           0.00495   08:03:01   2           0.00990   27:06      4           0.01980   13:12:01   6           0.02970   05:03:02   1           0.00495
  24:20      3           0.01485   12:02:02   3           0.01485   35:01:01   4           0.01980   14:04:01   1           0.00495   05:03:11   1           0.00495
  26:01:01   4           0.01980   14:02:01   4           0.01980   35:03:01   1           0.00495   14:05:01   2           0.00990   05:10      1           0.00495
  29:01:01   17          0.08416   15:02:01   3           0.01485   35:05:01   7           0.03465   14:10      1           0.00495   05:18      2           0.00990
  30:01:01   1           0.00495   15:05:02   14          0.06931   37:01:01   1           0.00495   14:18      1           0.00495   06:01:01   17          0.08416
  31:01:02   3           0.01485                                    38:02:01   16          0.07921   14:54:01   3           0.01485   06:02:01   2           0.00990
  32:01:01   1           0.00495   Total      202         1.00000   39:01:01   4           0.01980   15:01:01   5           0.02475   06:03:01   1           0.00495
  33:01:01   2           0.00990                                    39:09:01   1           0.00495   15:02:01   20          0.09901   06:04:01   1           0.00495
  33:03:01   22          0.10891                                    40:01:02   16          0.07921   15:02:02   1           0.00495   06:09:01   2           0.00990
  34:01:01   3           0.01485                                    40:02:01   1           0.00495   16:02:01   9           0.04455                          
  68:01:02   1           0.00495                                    40:06:01   4           0.01980                                    Total      202         1.00000
  74:02:01   1           0.00495                                    44:03:02   2           0.00990   Total      202         1.00000                          
                                                                    46:01:01   19          0.09406                                                           
  Total      202         1.0000                                     48:01:01   3           0.01485                                                           
                                                                    51:01:01   4           0.01980                                                           
                                                                    51:02:01   3           0.01485                                                           
                                                                    51:06:01   1           0.00495                                                           
                                                                    52:01:01   4           0.01980                                                           
                                                                    54:01:01   3           0.01485                                                           
                                                                    55:02:01   4           0.01980                                                           
                                                                    55:18      1           0.00495                                                           
                                                                    56:01:01   3           0.01485                                                           
                                                                    56:04      2           0.00990                                                           
                                                                    57:01:01   1           0.00495                                                           
                                                                    58:01:01   17          0.08416                                                           
                                                                    Total      202         1.00000                                                           

No tested loci showed any significant departure from the Hardy--Weinberg equilibrium; *p*-values for all homozygotes and all heterozygotes tests were 0.79 & 0.93, 0.73 & 0.93, 0.33 & 0.73, 0.68 & 0.89, and 0.40 & 0.74 for HLA- A, -B, -C, -DRB1, and -DQB1 loci, respectively. The results of the EW homozygosity test of neutrality are summarized in [Table 2](#T2){ref-type="table"}. *p*-values of F were 0.64, 0.37, 0.22, 0.44, and 0.76 for HLA- A, -B, -C, -DRB1, and -DQB1 loci, respectively.

###### 

Results of the Ewens--Watterson homozygosity test of neutrality.

  **Locus**   **Number of alleles**   ***F*~*obs*~**   ***F*~*exp*~**   ***p*-value**
  ----------- ----------------------- ---------------- ---------------- ---------------
  A           28                      0.1078           0.1055           0.6404
  B           41                      0.0576           0.0650           0.3709
  C           21                      0.1117           0.1483           0.2166
  DRB1        26                      0.1024           0.1154           0.4389
  DQB1        25                      0.1374           0.1210           0.7593

Haplotype Frequencies {#S3.SS2}
---------------------

[Tables 3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}, and [5](#T5){ref-type="table"} list the 20 most common two-locus, three-locus, and five-locus haplotypes. The most frequent haplotypes in the two-locus sets were A^∗^29:01:01∼B^∗^07:05:01 (6.93%), A^∗^33:03:01∼B^∗^58:01:01 (6.43%), A^∗^11:01:01∼B^∗^15:02:01 (5.87%), and DRB1^∗^12:02:01 ∼DQB1^∗^03:01:01 (21.28%), DRB1^∗^09:01:02∼DQB1^∗^03:03:02 (11.88%), DRB1^∗^10:01:01∼DQB1^∗^05:01:01 (7.42%). The two most frequent haplotypes in each three-locus set were A^∗^29:01:01 ∼C^∗^15:05:02∼B^∗^07:05:01 (6.93%) and A^∗^33:03:01∼B^∗^58:01:01 ∼DRB1^∗^03:01:01 (4.95%). The three most frequent five-locus haplotypes were A^∗^29:01:01∼C^∗^15:05:02∼B^∗^07:05:01∼DRB1^∗^ 10:01:01∼DQB1^∗^05:01:01 (4.46%), A^∗^33:03:01∼C^∗^03:02:02 ∼B^∗^58:01:01∼DRB1^∗^03:01:01∼DQB1^∗^02:01:01 (4.46%), and A^∗^11:01:01∼C^∗^08:01:01∼B^∗^15:02:01∼DRB1^∗^12:02:01∼DQB1^∗^ 03:01:01 (3.84%). The likelihood ratio test of linkage disequilibrium demonstrated that all two-, three- and five-locus associations were statistically significant (*p* \< 0.001). Data on the full two-locus, three-locus, five-locus, and ten-locus haplotype frequencies are described in [Supplementary Tables 1](#TS1){ref-type="supplementary-material"}, [2](#TS2){ref-type="supplementary-material"}, [3](#TS3){ref-type="supplementary-material"}, and [4](#TS4){ref-type="supplementary-material"}.

###### 

Haplotype frequencies of two-locus HLA.

  **A**      **B**      **Est. count**   **hap.freq**   **DRB1**   **DQB1**   **Est. count**   **hap.freq**
  ---------- ---------- ---------------- -------------- ---------- ---------- ---------------- --------------
  29:01:01   07:05:01   14.00            0.06931        12:02:01   03:01:01   43.00            0.21283
  33:03:01   58:01:01   13.00            0.06436        09:01:02   03:03:02   24.00            0.11881
  11:01:01   15:02:01   11.86            0.05869        10:01:01   05:01:01   15.00            0.07426
  02:07:01   46:01:01   10.40            0.05146        03:01:01   02:01:01   14.00            0.06931
  02:03:01   38:02:01   7.92             0.03922        08:03:02   06:01:01   11.00            0.05446
  11:01:01   40:01:02   7.70             0.03810        04:05:01   04:01:01   10.00            0.04950
  11:01:01   38:02:01   4.69             0.02322        16:02:01   05:02:01   9.00             0.04455
  02:07:01   15:02:01   4.15             0.02052        13:12:01   03:01:01   6.00             0.02970
  24:02:01   27:06:00   4.00             0.01980        15:02:01   05:01:01   6.00             0.02970
  24:07:01   35:05:01   4.00             0.01980        15:02:01   05:02:01   5.99             0.02966
  11:01:01   13:01:01   3.82             0.01891        07:01:01   02:02:01   4.00             0.01980
  11:01:01   15:25:01   3.61             0.01789        11:01:01   03:01:01   4.00             0.01980
  24:02:01   46:01:01   3.28             0.01624        04:03:01   03:02:01   3.00             0.01485
  11:01:01   39:01:01   3.00             0.01485        04:05:01   04:02:01   2.00             0.00990
  24:02:01   15:02:01   3.00             0.01485        04:06:01   03:02:01   2.00             0.00990
  24:02:01   15:25:01   2.39             0.01181        11:06:01   03:01:01   2.00             0.00990
  11:01:01   46:01:01   2.33             0.01151        13:02:01   06:09:01   2.00             0.00990
  24:02:01   40:01:02   2.23             0.01102        14:05:01   05:03:01   2.00             0.00990
  02:01:01   35:01:01   2.00             0.00990        14:54:01   05:02:01   2.00             0.00990
  02:01:01   40:01:02   2.00             0.00990        15:01:01   06:01:01   2.00             0.00990

###### 

Haplotype frequencies of three-locus HLA.

  **A**      **C**      **B**      **Est. count**   **hap.freq**   **A**      **B**      **DRB1**   **Est. count**   **hap.freq**
  ---------- ---------- ---------- ---------------- -------------- ---------- ---------- ---------- ---------------- --------------
  29:01:01   15:05:02   07:05:01   14.00            0.06931        33:03:01   58:01:01   03:01:01   10.00            0.04950
  33:03:01   03:02:02   58:01:01   13.00            0.06436        29:01:01   07:05:01   10:01:01   9.00             0.04455
  11:01:01   08:01:01   15:02:01   10.84            0.05367        11:01:01   15:02:01   12:02:01   8.43             0.04175
  02:07:01   01:02:01   46:01:01   10.38            0.05138        02:07:01   46:01:01   09:01:02   5.83             0.02886
  02:03:01   07:02:01   38:02:01   8.00             0.03960        02:03:01   38:02:01   08:03:02   4.00             0.01980
  11:01:01   04:03:01   15:25:01   5.00             0.02475        11:01:01   40:01:02   12:02:01   4.00             0.01980
  11:01:01   07:02:01   38:02:01   5.00             0.02475        24:02:01   27:06:00   12:02:01   4.00             0.01980
  11:01:01   07:02:01   40:01:02   5.00             0.02475        29:01:01   07:05:01   09:01:02   4.00             0.01980
  02:07:01   08:01:01   15:02:01   4.16             0.02059        02:07:01   15:02:01   12:02:01   3.17             0.01569
  24:07:01   04:01:01   35:05:01   4.00             0.01980        11:01:01   46:01:01   09:01:02   3.17             0.01569
  11:01:01   03:04:01   13:01:01   3.82             0.01891        24:02:01   15:25:01   15:02:01   3.00             0.01485
  24:02:01   01:02:01   46:01:01   3.28             0.01625        24:02:01   35:05:01   08:03:02   3.00             0.01485
  24:02:01   04:03:01   15:25:01   3.00             0.01485        24:02:01   15:02:01   12:02:01   2.40             0.01187
  24:02:01   03:04:01   27:06:00   3.00             0.01485        02:01:01   35:01:01   07:01:01   2.00             0.00990
  11:01:01   01:02:01   46:01:01   2.34             0.01158        02:01:01   40:01:02   09:01:02   2.00             0.00990
  02:01:01   03:03:01   35:01:01   2.00             0.00990        02:03:01   38:02:01   16:02:01   2.00             0.00990
  11:01:01   07:02:01   39:01:01   2.00             0.00990        02:07:01   46:01:01   11:01:01   2.00             0.00990
  11:02:01   07:02:01   40:01:02   2.00             0.00990        02:07:01   46:01:01   12:02:01   2.00             0.00990
  24:02:01   08:01:01   15:02:01   2.00             0.00990        11:01:01   07:02:01   10:01:01   2.00             0.00990
  24:02:01   04:01:01   35:05:01   2.00             0.00990        11:01:01   15:02:01   07:01:01   2.00             0.00990

###### 

Haplotype frequencies of five-locus HLA.

  **A**      **C**      **B**      **DRB1**   **DQB1**   **Est. count**   **hap.freq**
  ---------- ---------- ---------- ---------- ---------- ---------------- --------------
  29:01:01   15:05:02   07:05:01   10:01:01   05:01:01   9.00             0.04455
  33:03:01   03:02:02   58:01:01   03:01:01   02:01:01   9.00             0.04455
  11:01:01   08:01:01   15:02:01   12:02:01   03:01:01   7.76             0.03844
  02:07:01   01:02:01   46:01:01   09:01:02   03:03:02   5.76             0.02854
  11:01:01   01:02:01   46:01:01   09:01:02   03:03:02   4.23             0.02096
  02:03:01   07:02:01   38:02:01   08:03:02   06:01:01   4.00             0.01980
  02:07:01   08:01:01   15:02:01   12:02:01   03:01:01   3.23             0.01601
  11:01:01   07:02:01   40:01:02   12:02:01   03:01:01   3.00             0.01485
  24:07:01   04:01:01   35:05:01   12:02:01   03:01:01   3.00             0.01485
  29:01:01   15:05:02   07:05:01   09:01:02   03:03:02   3.00             0.01485
  02:01:01   03:03:01   35:01:01   07:01:01   02:02:01   2.00             0.00990
  02:03:01   07:02:01   38:02:01   12:02:01   05:02:01   2.00             0.00990
  02:07:01   08:01:01   15:02:01   13:12:01   03:01:01   2.00             0.00990
  02:07:01   01:02:01   46:01:01   12:02:01   03:01:01   2.00             0.00990
  11:01:01   07:02:01   07:02:01   10:01:01   05:01:01   2.00             0.00990
  11:01:01   08:01:01   15:02:01   07:01:01   02:02:01   2.00             0.00990
  11:01:01   07:02:01   15:25:01   15:02:01   03:01:01   2.00             0.00990
  11:01:01   07:02:01   38:02:01   15:02:01   05:01:01   2.00             0.00990
  11:01:01   07:02:01   39:01:01   14:54:01   03:01:01   2.00             0.00990
  11:01:01   03:02:02   58:01:01   03:01:01   02:01:01   2.00             0.00990

Population Genetic Analysis {#S3.SS3}
---------------------------

Pairwise LD estimates are given in [Table 6](#T6){ref-type="table"} with D′ and Wn. The LD of allele pairs was always statistically significant with 1,000 permutations. LD plots based on ALD measures for HLA loci are shown in [Figure 1](#F1){ref-type="fig"}. Generally, the associations between HLA loci within HLA classes were stronger than between HLA loci in different classes, except for the case of B & DRB1 loci. Both symmetric and asymmetric LD showed that the strongest genetic linkages were between C & B loci and DRB1 & DQB1 loci.

###### 

Pairwise linkage disequilibrium estimates.

  **Locus pair**   **D′**    **Wn**    **\#permutations**   ***p*-value**
  ---------------- --------- --------- -------------------- ---------------
  A:C              0.68522   0.56686   999                  0.0000
  A:B              0.76923   0.61971   999                  0.0000
  A:DRB1           0.63441   0.51613   999                  0.0000
  A:DQB1           0.63335   0.48973   999                  0.0000
  C:B              0.91995   0.84507   999                  0.0000
  C:DRB1           0.66870   0.51054   999                  0.0000
  C:DQB1           0.65889   0.48280   999                  0.0000
  B:DRB1           0.79814   0.58696   999                  0.0000
  B:DQB1           0.77352   0.61127   999                  0.0000
  DRB1:DQB1        0.93176   0.70996   999                  0.0000

![LD plot based on asymmetric linkage disequilibrium (ALD) measures for HLA genes.](fgene-11-00383-g001){#F1}

The PCA plot of eight Asian populations is shown in [Figure 2](#F2){ref-type="fig"}. The percentage of variability represented by the first three principal components was 82.08%. The first, second, and third principal components demonstrated 47.29, 20.72, and 14.07% of the variances in allele frequencies between populations, respectively. The first principal component distinguished between the South-East Asian, Han Chinese, and East Asian (Japanese and South Korean) populations. The second principal component separated the Han Chinese, Kinh Vietnamese, and Thai from the Indonesian and Malaysian populations. The third principal component distinguished the Kinh Vietnamese from the Han Chinese and other South-East Asian populations. A homogeneous allele frequency distribution of HLA-A, -B, and -DRB1 was observed between the northern and southern Kinh Vietnamese ([@B24]). Japanese and South Korean also presented a similar distribution of HLA alleles.

![Principal component analysis (PCA) plot of eight populations based on HLA-A, -B, and -DRB1 allele frequencies. PC1, principal component 1; PC2, principal component 2; PC3, principal component 3.](fgene-11-00383-g002){#F2}

Discussion {#S4}
==========

In recent years, various HLA-typing methods using different NGS approaches have been performed. NGS-based HLA typing can provide high-resolution, unambiguous, phase-defined HLA alleles, avoiding several limitations compared to traditional sequence-based typing methods ([@B11]). Our study showed the distribution of HLA-A, -B, -C, -DRB1, and -DQB1 alleles and haplotypes among the southern Kinh Vietnamese population using high-resolution NGS typing (reported at 3-field resolution, which remains ambiguous in many cases). Highly polymorphic sequences at both HLA class I and class II loci resulted in 28 alleles for HLA-A, 41 alleles for HLA-B, 21 alleles for HLA-C, 26 alleles for HLA-DRB1, and 25 alleles for HLA-DQB1.

The most frequent HLA-A alleles found in this study were A^∗^11:01:01 and A^∗^24:02:01. The high frequency of HLA-A^∗^11:01 and A^∗^24:02:01 is consistent with previous typing results of northern Kinh Vietnamese and other Asian populations, such as the Chinese, Thai, Indonesian, Korean, and Japanese ([@B31]; [@B24]; [@B56]; [@B42]; [@B29]; [@B38]). Among HLA-C alleles identified in this study, C^∗^07:02:01 was found to be widely distributed globally, while C^∗^01:02:01 was common in Asians ([@B31]; [@B42]; [@B29]; [@B38]). The predominance of HLA-B^∗^15 alleles is a major distinguishing characteristic of the Kinh population from the Thai and Chinese groups ([@B42]; [@B38]). However, this predominance is similar in the Indonesian population ([@B56]). Detailed comparison of B^∗^15 alleles among the Vietnamese and Indonesians showed similar popularity of B^∗^15:02, while the second most-frequent B^∗^15 alleles were B^∗^15:25:01 and B^∗^15:13, respectively. HLA-B^∗^07:05:01, the only B^∗^07 allele found in Kinh Vietnamese, was the sixth most-frequent HLA-B allele, whereas it is a minor allele in other Asian groups ([@B53]).

At the HLA-DRB1 locus, the most frequent allele was HLA-DRB1^∗^12:02:01 (22.28%), which is common among South-East Asian populations ([@B10]; [@B24]; [@B56]; [@B38]) but infrequent among Northern East Asian groups, including Japanese and Koreans ([@B31]; [@B29]). Another similarity observed between the Kinh Vietnamese, Muong Vietnamese, and other South-East Asians is the predominance of HLA-DRB1^∗^15:02:01 over HLA-DRB1^∗^15:01:01, in contrast to what was observed among Northern East Asian populations. The first and second-most predominance of HLA-DQB1^∗^03:01:01 (28.71%) and DQB1^∗^03:03:02 (12.38%) in Kinh Vietnamese is similar among East Asian populations, including Taiwanese, Chinese, Korean, and Japanese ([@B40]; [@B31]; [@B55]), while the third-most predominance of HLA-DQB1^∗^05:02:01 (9.90%) is closer to the characteristics of the Thai population ([@B39]). In Kinh Vietnamese, the predominance of DQB1^∗^05:01 over DQB1^∗^05:02 in our data was consistent with data from a previous study ([@B24]). However, Muong Vietnamese showed a contrary distribution (48%) of DQB1^∗^05:02 ([@B10]).

Based on the haplotype calculation, most two-, three-, and five-locus HLA haplotypes with predominant frequencies were consistent with a previous report on northern Kinh Vietnamese ([@B24]). Despite being the sixth most common HLA-B allele, B^∗^07:05:01 was strongly associated with A^∗^29:01:01 and lead to the common signature haplotypes of the Kinh population, including A^∗^29:01:01∼B^∗^07:05:01, A^∗^29:01:01∼C^∗^15:05:02∼B^∗^07:05:01, and A^∗^29:01:01∼B^∗^07:05:01∼DRB1^∗^10:01:01. Interestingly, A^∗^29:01:01∼C^∗^15:05:02∼B^∗^07:05:01∼DRB1^∗^10:01:01∼DQB1^∗^ 05:01:01 was the most common five-locus haplotype (4.45%). The predominance of these haplotypes might be a unique feature of the Kinh Vietnamese. The strong association of DRB1^∗^12:02:01 and DQB1^∗^03:01:01 in HLA class II found in our study is also well-described in Thai, Indonesian, and surrounding populations ([@B20]; [@B39]; [@B34]).

The strong associations between all pairs of HLA loci in southern Kinh Vietnamese indicate a low probability of recombination between alleles from these loci; therefore, individuals who carry allele haplotypes in LD are more likely to find a donor with matching haplotypes. The strong LD between class I HLA loci has also been well-described in Asian populations ([@B42]; [@B29]), while the nearly complete LD of DRB1 and DQB1 loci has been observed in Han Chinese ([@B50]). PCA showed a homogeneous HLA-A, -B, and -DRB1 allele distribution of northern and southern Kinh Vietnamese. The allele distribution also demonstrated a closer relationship between Kinh Vietnamese and other South-East Asian groups than with the Han Chinese group. The Japanese were closely grouped with South Koreans, reflecting the similarity in HLA distribution among East Asian populations.

Previously, HLA typing of Asian populations were mainly based on SSO-PCR ([@B31]; [@B56]; [@B42]; [@B29]; [@B38]). Due to the finite amounts of probes designed to recognize the polymorphisms in the core exons, this technique only allows certain allele typing with 2-field resolution. Alleles were then assigned by software based on SSO-PCR patterns. Hence, the number of alleles determined by SSO-PCR is limited. With full-length HLA sequences provided by NGS, HLA-typing software programs align sequence reads to the entire IMGT/HLA Database to find the best-matching alleles. NGS-based typing, therefore, can provide diversified HLA assignments. In our study, the number of identified alleles (141 alleles) in 101 subjects was higher compared to the previous study in northern Kinh Vietnamese (115 identified alleles in 170 subjects) ([@B24]). Similar results were obtained in the Thai population, in which the number of HLA alleles determined by NGS and SSO-PCR were 156 and 144, respectively ([@B21]; [@B38]).

Recently, it has been shown that both high-resolution HLA typing and haplotyping are important in hematopoietic stem cell transplantation for both unrelated and related donors in reducing post-transplantation adverse outcomes ([@B2]; [@B9]); a single high-resolution HLA mismatch may lead to a similar negative effect on outcomes as a low-resolution one ([@B19]; [@B4]). Therefore, it has been suggested that high-resolution HLA typing can reduce the likelihood of missing a clinically significant mismatch compared to traditional low-resolution typing, especially in developing countries where high-resolution HLA typing methods are not widely available ([@B2]). With a 3-field resolution, our typing process can distinguish between HLA-A^∗^24:02:01, HLA-A^∗^24:02:13, and HLA-A^∗^24:02:40 and between HLA-C^∗^07:01:01 and HLA-C^∗^07:01:02, which are considered high-resolution mismatches. Although traditional SBT can separate these alleles, it is time and resource-consuming.

Our study had several limitations that should be considered in interpreting the results. First of all, the absence of other class II HLA descriptions (HLA-DQA1, -DPA1, and -DPB1) makes the study less informative, especially for population genetic purposes. Second, the study sample size was relatively small. This may increase the risk of missing rare HLA alleles in Kinh Vietnamese and reduce the significance of statistical analysis. These limitations will necessitate further studies with comprehensive allele descriptions and larger sample sizes.

It is now also well-recognized that HLA molecules are strongly associated with the pathophysiology of adverse drug reactions, including severe cutaneous adverse reaction (SCAR), agranulocytosis, and liver injury. High prevalence of HLA-B^∗^15:02, B^∗^58:01, B^∗^38:02, DRB1^∗^08:03, and C^∗^03:02 suggests that the Kinh Vietnamese population is at a high risk of developing carbamazepine-induced SCAR, allopurinol-induced SCAR, methimazole-induced agranulocytosis, and methimazole-induced liver injury, respectively ([@B28]; [@B12]; [@B48]; [@B32]), while the risk of developing dapsone or abacavir-induced hypersensitivity is low due to the low prevalence of HLA-B^∗^13:01 and B^∗^57:01 ([@B36]; [@B45]; [@B47]). Therefore, HLA information is important to clinicians for treatment modality adoption and to healthcare policymakers for constructing personalized medicine strategies.

Conclusion {#S5}
==========

To our knowledge, this is the first report of high-resolution HLA-A, -B, -C, -DRB1, and -DQB1 allele and haplotype frequencies in southern Kinh Vietnamese individuals. These data display the homogenous distribution of HLA between the northern and southern Kinh population in Vietnam. Although the characteristics of HLA class I and II alleles and haplotypes in the Kinh Vietnamese are similar to those in the Thai, Malaysian, and Indonesian populations, they still retain unique characteristics. Data from this study will be useful in anthropology, immune-mediated diseases, transplantation therapy, and drug hypersensitivity.
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